PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Pantaflix AG (PAL.DE)
1.170.03 (-2.50%)
1.14 - 1.17
1.10 - 1.60
14.0K / 2.1K (Avg.)
-9.00 | -0.13
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative gross profit growth while PGN.DE is at 60.71%. Joel Greenblatt would examine cost competitiveness or demand decline.
0.00%
EBIT growth below 50% of PGN.DE's 734.84%. Michael Burry would suspect deeper competitive or cost structure issues.
-13.47%
Negative operating income growth while PGN.DE is at 736.69%. Joel Greenblatt would press for urgent turnaround measures.
No Data
No Data available this quarter, please select a different quarter.
-0.57%
Negative EPS growth while PGN.DE is at 1253.08%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-0.57%
Negative diluted EPS growth while PGN.DE is at 1253.08%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
161.18%
OCF growth under 50% of PGN.DE's 1891.13%. Michael Burry might suspect questionable revenue recognition or rising costs.
102.27%
FCF growth similar to PGN.DE's 109.28%. Walter Schloss would attribute it to parallel capital spending and operational models.
66.79%
10Y revenue/share CAGR above 1.5x PGN.DE's 36.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
66.79%
5Y revenue/share CAGR above 1.5x PGN.DE's 36.63%. David Dodd would look for consistent product or market expansions fueling outperformance.
66.79%
3Y revenue/share CAGR at 75-90% of PGN.DE's 76.28%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-128.22%
Negative 10Y net income/share CAGR while PGN.DE is at 188.35%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-128.22%
Negative 5Y net income/share CAGR while PGN.DE is 188.35%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-128.22%
Negative 3Y CAGR while PGN.DE is 276.29%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-65.43%
We cut SG&A while PGN.DE invests at 7.70%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.